Page 6 - Covid Newsletter 11_10

ICMR invites expression of interest (EOI) for participation in ‘Indian
Clinical Trial & Education Network (INTENT)’
Indian Council of Medical Research (ICMR) calls for expression of interest (EOI) for participation in ‘Indian Clinical Trial & Education Network (INTENT)’. All government medical colleges/ institutes, private medical colleges/institutes, hospitals with experience of conducting RCTs and ICMR institutes can apply for advanced centre for clinical trial.
INTENT envisages providing evidence-based, cost effective, scientifically sound, and culturally appropriate solutions to diseases and health issues of national and/or regional importance. It will provide a single platform to conduct a range of randomised clinical trials (RCT) that will enable harmonisation of trial methods, pooling of results and timely completion of the projects, along with an inclusive representation of the diverse Indian communities. Additionally, this network will be at the forefront for capacity building of a pool of health researchers across the country. The trainees will acquire requisite skills to plan and conduct RCTs and to analyse and disseminate the results that could inform policy and practice.
Structure of Indian Clinical Trial & Education Network
Last date to apply: 15 October 2021
Contact info
Dr Aparna Mukherjee
intent.icmr@gmail.com
Website link:
https://www.icmr.gov.in/pdf/tender/EoI_INTENT.pdf
THSTI, Faridabad collaborates with Nanogen Pharmaceutical Biotechnology, Vietnam, for developing a new vaccine against COVID-19
After helping Indian companies for clinical trials/development of vaccines for COVID-19 including Dr Reddy’s (Sputnik), Zydus Cadilla (DNA vaccine), and Biological E, Translational Health Science and Technology Institute (THSTI), Department of Biotechnology, M/o Science & Technology, Government of India has entered into a research collaboration with Nanogen Pharmaceutical Biotechnology JSC, a Vietnamese pharmaceutical company, which is developing a new
VOL. IV ISSUE 12
VIGYAN PRASAR 2
COVID-19 SCIENCE & TECHNOLOGY EFFORTS IN INDIA